Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for α -fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 5, 2006, Pages 869-873

  Okuda, Hiroaki ^a   Shiratori, Keiko ^a   Yamamoto, Masakazu ^a   Takasaki, Ken ^a   Nakano, Masayuki ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

Author keywords

Carbohydrate antigen (CA) 19 9; Combined hepatocellular and cholangiocarcinoma; Hepatocellular carcinoma (HCC); Intrahepatic cholangiocarcinoma (ICC); Lectin reactive fetoprotein (AFP L3)

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; LECTIN; LECTIN REACTIVE ALPHA FETOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 33646937532     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04257.x     Document Type: Article

References (29)

1. Okuda K Okuda H Primary liver cell carcinoma In Benhamou J-P McIntyre N Rizzetto M Rodes J eds Oxford Textbook of Clinical Hepatology 2nd edn Vol. 2 New York Oxford University Press 1999 1491 530
2. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment AnnSurg 1990 211 277 87
3. Ikai I Itai Y Okita K et al. Report of the 15th follow-up survey of primary liver cancer HepatolRes 2004 28 21 9
4. Shaib YH El-Serag HB Davila JA Morgan R McGlynn KA Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study Gastroenterology 2005 128 620 6
5. Colombari R Tsui WMS Biliary tumors of the liver SeminLiver Dis 1995 15 402 13
6. Altaee MY Johnson PJ Farrant JM Williams R Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma Cancer 1991 68 2051 5
7. Tomimatsu M Ishiguro N Taniai M et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma) in Japan Cancer 1993 72 683 8
8. Yamamoto M Takasaki K Nakano M Saito A Minute nodular intrahepatic cholangiocarcinoma Cancer 1998 82 2145 9
9. Nomura F Ohnishi K Tanabe Y Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels Cancer 1989 64 1700 7
10. Yamashita F Tanaka M Satomura S Tanikawa K Monitoring of lectin-reactive α-fetoprotein in patients with hepatocellular carcinoma treated using transcatheter arterial embolization EurJGastroenterolHepatol 1995 7 627 33
11. Okuda H Obata H Nakanishi T Furukawa R Hashimoto E Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma: a clinical and experimental study JHepatol 1987 4 357 63
12. Okuda H Nakanishi T Takatsu K et al. Serum levels of des-γ-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma Cancer 2000 88 544 9
13. Tomimatsu M Obata H Diagnosis of cholangiocellular carcinoma In Tobe T Kameda H Okudaira M et al. eds Primary Liver Cancer in Japan Tokyo Springer 1992 393 401
14. Yamamoto M Ariizumi S Otsubo T et al. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma JSurgOncol 2004 87 80 4
15. Qin XL Wang ZR Shi JS Lu M Wang L He QR Utility of serum CA 19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA World JGastroenterol 2004 10 427 32
16. Okuda H Saito A Haruyama K et al. Unique clinicopathological features of patients with primary malignant hepatic tumors who are seropositive for lectin-reactive α-fetoprotein alone: report of five cases JGastroenterolHepatol 2004 19 113 14
17. Okuda H Saito A Shiratori K Yamamoto M Takasaki K Nakano M Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for α-fetoprotein-L3 alone in comparison with other patients seropositive for α-fetoprotein-L3 JGastroenterolHepatol 2005 20 759 64
18. Taketa K Ichikawa E Taga H Hirai H Antibody-affinity blotting, a sensitive technique for the detection of α-fetoprotein separated by lectin-affinity electrophoresis in agarose gels Electrophoresis 1985 6 492 7
19. Taketa K Sekiya C Namiki M et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions Gastroenterology 1990 99 506 18
20. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer 2nd English edn. Tokyo Kanehara 2003
21. Harada K Terada T Nakanuma Y et al. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver AmJGastroenterol 1993 88 1968 9
22. Tanaka S Yamamoto T Tanaka H et al. Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: immunohistochemical evidence HepatolRes 2005 32 52 7
23. Kobayashi M Ikeda K Saitoh S et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C-virus related cirrhosis Cancer 2000 88 2471 7
24. Wang WL Gu GY Hu M Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma World JGastroenterol 1998 4 392 6
25. Yamamoto M Takasaki K Yoshikawa T et al. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma JSurgOncol 1998 69 162 7
26. Ng IO Shek TW Nicholls J Ma LT Combined hepatocellular- cholangiocarcinoma: a clinicopathological study JGastroenterolHepatol 1998 13 34 40
27. Yano Y Yamamoto J Kosuge T et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases Jpn JClinOncol 2003 33 283 7
28. Sasaki M Nakanuma Y Ho SB Kim YS Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles AmJClinPathol 1998 109 302 8
29. Yano H Iemura A Haramaki M et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions JHepatol 1996 24 413 22